Key market opportunities in the CDMO sector include rising outsourcing demands for biologics and HPAPIs, driven by R&D costs ...
Automation and AI are revolutionizing the pharmaceutical industry, optimizing technical development and enabling faster, more ...
In 2022, the combined research and development (R&D) expenditure of the U.S. pharmaceutical industry consisted of more than $100 billion. While this is a significantly expansive market, approximately ...
CHICAGO--(BUSINESS WIRE)--Tempus, a leader in artificial intelligence and precision medicine, today announced a collaboration with JW Pharmaceutical, one of the most established pharmaceutical ...
Overview AI is speeding up drug discovery by analyzing large biological and chemical data in a short time.Deep learning and AI systems help design new drug mole ...
The pharmaceutical industry operates under an uncompromising mandate: zero defects. Every tablet, capsule, vial, or syringe must meet exacting standards for dosage, purity, and sterility. This ...
Dr. Rob Burgess shares how Sino Biological empowers global biomedical research through precision, quality, and ...
FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) announced today that Stacey Ma, PhD will join the company as Executive Vice President, Pharmaceutical Development and ...
Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") announced today that its China holding company Eisai China Holdings Ltd. (Location: Suzhou, Jiangsu Province) has signed an agreement ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results